Control of the binding of a vesamicol analog to the vesicular acetylcholine transporter

Neuroreport. 1999 Sep 9;10(13):2783-7. doi: 10.1097/00001756-199909090-00016.

Abstract

4-Aminobenzovesamicol was used to test whether activation of protein kinase C protects the vesicular acetylcholine transporter from interaction with vesamicol-like drugs. The essentially irreversible vesamicol analog inhibits the release of newly synthesized [3H]acetylcholine from stimulated hippocampal slices. Prior activation of protein kinase C with a phorbol ester prevented the inhibition of [3H]acetylcholine release, but activation of protein kinase C after the exposure to the irreversible analog did not prevent the effect of the drug. Binding of 4-aminobenzovesamicol in hippocampal synaptosomes, assayed using [3H]vesamicol and back-titration, was decreased by activation of protein kinase C prior to analog exposure but not by activation subsequent to exposure. We propose that phosphorylation of the vesicular acetylcholine transporter prevents the binding of vesamicol-like drugs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcholine / antagonists & inhibitors
  • Acetylcholine / biosynthesis
  • Animals
  • Carrier Proteins / metabolism*
  • Electric Stimulation
  • Enzyme Activation / physiology
  • Female
  • Hippocampus / metabolism
  • In Vitro Techniques
  • Male
  • Membrane Transport Proteins*
  • Piperidines / metabolism*
  • Piperidines / pharmacology
  • Protein Kinase C / metabolism
  • Rats
  • Rats, Wistar
  • Vesicular Acetylcholine Transport Proteins
  • Vesicular Transport Proteins*

Substances

  • 4-aminobenzovesamicol
  • Carrier Proteins
  • Membrane Transport Proteins
  • Piperidines
  • Slc18a3 protein, rat
  • Vesicular Acetylcholine Transport Proteins
  • Vesicular Transport Proteins
  • Protein Kinase C
  • Acetylcholine